Abstract
The structural and functional properties of group 6 metal complexes with scorpionate ligands, used as synthetic analogues for the binding sites of the molybdenum and tungsten enzymes, are the subject of the present review. The group 6 elements molybdenum and tungsten are the only second and third row transition metals essential to all forms of life on Earth. Molybdenum is found at the active sites of nitrogenase and all of the more than 50 known Mo-molybdopterin (Mo- MPT) enzymes that play vital roles in plant, animal, and human health, the carbon, sulfur, and nitrogen cycles, biofeedback systems, and the control of global climate; tungsten is also associated with MPTbased ligands in all its known biological manifestations. Chemical approaches to molybdenum enzyme sites have been directed toward mimicking a portion of the structural center in order to ascertain the role of that particular feature of the center on the chemical reactivity and the spectroscopic properties of the center. Here we attempt to analyze the overall progress on synthetic analogues of these enzyme centers and dissect the contributions of systems in which coordination spheres contain poly(pyrazolyl)borate ligands, focusing primarily on research that has appeared since the structures of the active sites of representative enzymes have become known.
Keywords: Tris(pyrazolyl)borates, molybdenum enzymes, biomimetic, model complexes
Current Bioactive Compounds
Title: Chemistry and Relevant Biomimetic Applications of Group 6 Metals Systems Supported by Scorpionates
Volume: 5 Issue: 4
Author(s): Maura Pellei, Grazia Papini, Giancarlo Gioia Lobbia and Carlo Santini
Affiliation:
Keywords: Tris(pyrazolyl)borates, molybdenum enzymes, biomimetic, model complexes
Abstract: The structural and functional properties of group 6 metal complexes with scorpionate ligands, used as synthetic analogues for the binding sites of the molybdenum and tungsten enzymes, are the subject of the present review. The group 6 elements molybdenum and tungsten are the only second and third row transition metals essential to all forms of life on Earth. Molybdenum is found at the active sites of nitrogenase and all of the more than 50 known Mo-molybdopterin (Mo- MPT) enzymes that play vital roles in plant, animal, and human health, the carbon, sulfur, and nitrogen cycles, biofeedback systems, and the control of global climate; tungsten is also associated with MPTbased ligands in all its known biological manifestations. Chemical approaches to molybdenum enzyme sites have been directed toward mimicking a portion of the structural center in order to ascertain the role of that particular feature of the center on the chemical reactivity and the spectroscopic properties of the center. Here we attempt to analyze the overall progress on synthetic analogues of these enzyme centers and dissect the contributions of systems in which coordination spheres contain poly(pyrazolyl)borate ligands, focusing primarily on research that has appeared since the structures of the active sites of representative enzymes have become known.
Export Options
About this article
Cite this article as:
Pellei Maura, Papini Grazia, Lobbia Gioia Giancarlo and Santini Carlo, Chemistry and Relevant Biomimetic Applications of Group 6 Metals Systems Supported by Scorpionates, Current Bioactive Compounds 2009; 5 (4) . https://dx.doi.org/10.2174/157340709789816456
DOI https://dx.doi.org/10.2174/157340709789816456 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial [Human Methylome Variation and the Rise of Epigenetic Epidemiology]
Current Pharmacogenomics and Personalized Medicine Biomedical Hypothesis Generation by Text Mining and Gene Prioritization
Protein & Peptide Letters Heat Shock Protein 90 Inhibitors as Therapeutic Agents
Recent Patents on Anti-Cancer Drug Discovery The Exploitation of Toll-like Receptor 3 Signaling in Cancer Therapy
Current Pharmaceutical Design High Content Screening for G Protein-Coupled Receptors Using Cell-Based Protein Translocation Assays
Combinatorial Chemistry & High Throughput Screening New Approaches to the Modulation of the Cyclooxygenase-2 and 5-Lipoxygenase Pathways
Current Topics in Medicinal Chemistry SUMOylation Modulates CFTR Biogenesis: Is the Pathway Druggable?
Current Drug Targets microRNA as Biomarkers and Regulator of Cardiovascular Development and Disease
Current Pharmaceutical Design Therapeutic Peptide Mimetics Looking for a Turn to Block Aberrant Players of Malignancy
Current Cancer Therapy Reviews Strategic Combination Therapies for Ovarian Cancer
Current Cancer Drug Targets Synthesis and Evaluation of Cytotoxic Activity of Certain Benzo[h]chromene Derivatives
Anti-Cancer Agents in Medicinal Chemistry The In-Situ One-Step Synthesis of a PDC Macromolecular Pro-Drug and the Fabrication of a Novel Core-Shell Micell
Current Pharmaceutical Design Inhibitors of the Ubiquitin-Proteasome System and the Cell Death Machinery: How Many Pathways are Activated?
Current Molecular Pharmacology Prophylactic Surgery to Reduce the Risk of Developing Breast Cancer:Issues and Clinical Implications
Current Women`s Health Reviews Receptor-Specific Peptides for Targeting of Liposomal, Polymeric, and Dendrimeric Nanoparticles in Cancer Diagnosis and Therapy
Current Molecular Imaging (Discontinued) Utilization of Enzyme Inhibitors in Study of Mechanism Underlying apoA-I-mediated HDL Generation in Rat Brain Astrocytes
Current Enzyme Inhibition Nutraceuticals, Nutritional Therapy, Phytonutrients, and Phytotherapy for Improvement of Human Health: A Perspective on Plant Biotechnology Application
Recent Patents on Biotechnology Targeted Protein Degradation: An Emerging Therapeutic Strategy in Cancer
Anti-Cancer Agents in Medicinal Chemistry Cytokine/Antibody Complexes: An Emerging Class of Immunostimulants
Current Pharmaceutical Design Src Inhibitors and Angiogenesis
Current Pharmaceutical Design